TGFB1 and neoplasm: Overcoming tumor microenvironment suppression through miR-155 targeting TGF-β pathways is a sophisticated strategy to make CAR T cells resistant to immunosuppressive signals while boosting their effector functions within hostile tumor environments [165,166].